BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32580247)

  • 21. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.
    Ma K; Zhang C; Li W
    Chem Biol Interact; 2020 Nov; 331():109275. PubMed ID: 33010222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1.
    Jiang R; Zhang C; Liu G; Gu R; Wu H
    J Cell Biochem; 2017 Nov; 118(11):3765-3774. PubMed ID: 28379605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
    Shi Y; Huang J; Zhou J; Liu Y; Fu X; Li Y; Yin G; Wen J
    Oncol Rep; 2015 Jul; 34(1):399-406. PubMed ID: 25998694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
    Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
    Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling.
    Liu X; Zhou X; Xu H; He Z; Shi X; Wu S
    DNA Cell Biol; 2017 Sep; 36(9):775-780. PubMed ID: 28777670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
    Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
    Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LAIR-1 overexpression inhibits epithelial-mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism.
    Zhang J; Zhang Y; Cheng S; Mu Y; Liu Y; Yi X; Jiang D; Ding Y; Zhuang R
    World J Surg Oncol; 2020 Jun; 18(1):136. PubMed ID: 32563267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
    Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
    J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells.
    Ma L; Zhang L; Guo A; Liu LC; Yu F; Diao N; Xu C; Wang D
    Pathol Res Pract; 2019 Jun; 215(6):152412. PubMed ID: 31000382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-determining region Y-box protein 3 induces epithelial-mesenchymal transition in osteosarcoma cells via transcriptional activation of Snail1.
    Qiu M; Chen D; Shen C; Shen J; Zhao H; He Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):46. PubMed ID: 28335789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
    Liu L; Wang R; Zhang Z; Wang X
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.
    Tokunaga A; Oya T; Ishii Y; Motomura H; Nakamura C; Ishizawa S; Fujimori T; Nabeshima Y; Umezawa A; Kanamori M; Kimura T; Sasahara M
    J Bone Miner Res; 2008 Sep; 23(9):1519-28. PubMed ID: 18410236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SOX6 is downregulated in osteosarcoma and suppresses the migration, invasion and epithelial-mesenchymal transition via TWIST1 regulation.
    Wang Z; Li J; Li K; Xu J
    Mol Med Rep; 2018 May; 17(5):6803-6811. PubMed ID: 29512775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.